BIOMARKER:

PLCG2 mutation

Entrez ID:

Related biomarkers:

‹

›

PLCG2 mutation PLCG2 mutation	Chronic Lymphocytic Leukemia CLL	PLCG2 mutation PLCG2 mutation	Chronic Lymphocytic Leukemia CLL	venetoclax Sensitive: C2 – Inclusion Criteria	venetoclax Sensitive: C2 – Inclusion Criteria
PLCG2 mutation PLCG2 mutation	Follicular Lymphoma Follicular Lymphoma	PLCG2 mutation PLCG2 mutation	Follicular Lymphoma Follicular Lymphoma	R-CHOP Resistant: C3 – Early Trials	R-CHOP Resistant: C3 – Early Trials
PLCG2 mutation PLCG2 mutation	Myelodysplastic Syndrome MDS	PLCG2 mutation PLCG2 mutation	Myelodysplastic Syndrome MDS	lenalidomide Resistant: C3 – Early Trials	lenalidomide Resistant: C3 – Early Trials
PLCG2 mutation PLCG2 mutation	Chronic Lymphocytic Leukemia CLL	PLCG2 mutation PLCG2 mutation	Chronic Lymphocytic Leukemia CLL	ibrutinib Resistant: C3 – Early Trials	ibrutinib Resistant: C3 – Early Trials